Early engraftment and full-donor chimerism after single-cord blood plus third-party donor dual transplantation in patients with high-risk acute leukemia
- PMID: 23933757
- DOI: 10.1038/bmt.2013.113
Early engraftment and full-donor chimerism after single-cord blood plus third-party donor dual transplantation in patients with high-risk acute leukemia
Similar articles
-
Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit.Blood. 2010 Jan 28;115(4):757-65. doi: 10.1182/blood-2009-07-228999. Epub 2009 Oct 12. Blood. 2010. PMID: 19822900 Free PMC article.
-
Reduced-intensity cord blood transplantation without prior remission induction therapy induces durable remission in adult patients with relapsed acute leukemia after the first allogeneic transplantation.Eur J Haematol. 2011 Mar;86(3):268-71. doi: 10.1111/j.1600-0609.2010.01555.x. Epub 2010 Dec 22. Eur J Haematol. 2011. PMID: 21114536 No abstract available.
-
Long-term persistent donor-recipient mixed chimerism without disease recurrence after myeloablative single-unit cord blood transplantation in adult acute myeloid leukemia following myelodysplastic syndrome.Leuk Lymphoma. 2017 Dec;58(12):2973-2975. doi: 10.1080/10428194.2017.1318440. Epub 2017 May 16. Leuk Lymphoma. 2017. PMID: 28509586 No abstract available.
-
Unrelated donor umbilical cord blood transplant versus unrelated hematopoietic stem cell transplant in patients with acute leukemia: A meta-analysis and systematic review.Blood Rev. 2018 May;32(3):192-202. doi: 10.1016/j.blre.2017.11.003. Epub 2017 Nov 15. Blood Rev. 2018. PMID: 29174416
-
Allogeneic hematopoietic cell transplantation (HCT) following reduced-intensity conditioning in patients with acute leukemias.Crit Rev Oncol Hematol. 2005 Nov;56(2):275-81. doi: 10.1016/j.critrevonc.2005.03.016. Epub 2005 Oct 5. Crit Rev Oncol Hematol. 2005. PMID: 16213741 Review.
Cited by
-
Sequential Transplantation of Haploidentical Stem Cell and Unrelated Cord Blood With Using ATG/PTCY Increases Survival of Relapsed/Refractory Hematologic Malignancies.Front Immunol. 2021 Nov 4;12:733326. doi: 10.3389/fimmu.2021.733326. eCollection 2021. Front Immunol. 2021. PMID: 34804017 Free PMC article. Clinical Trial.
-
Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.Bone Marrow Transplant. 2015 Aug;50(8):1037-56. doi: 10.1038/bmt.2015.6. Epub 2015 Mar 23. Bone Marrow Transplant. 2015. PMID: 25798672 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical